nivolumab
bms
['nivo', 'improve ', 'nivolumab']
neoadjuvant nivolumab did not improve rfs. the definition of relapse was clouded by those patients who did not have surgery. mixed histology, short follow up and t1/2 disease complicates things. this design is novel and deserve praise (esp as investigator led) #esmo2022 . 
Interested in Urology Cancers, biomarkers and drug development.